ILD2 - Innovative Learning Destination for Interstitial Lung Disease
ILD2 is a site dedicated to Interstitial Lung Disease. It is intended to deliver scientific information about ILD through microlearning. It hosts a collection of short videos, case presentations, learning courses, a library of publications and other scientific content related to ILD and its management.
Discussion on the 2 replicate clinical trials conducted to evaluate the efficacy and safety of nintedanib in patients with Idiopathic Pulmonary Fibrosis.